Shannon N. Westin

Dec 9, 2024 | mdanderson.org | Shannon N. Westin

“Partial hysterectomy” is one of those phrases that isn’t very specific. It’s not always clear what the term means. So, most doctors try to avoid using it. But when people speak of a partial hysterectomy, the scientific term for what they’re describing is usually a supracervical hysterectomy. That’s a procedure in which the bulk of the uterus is surgically removed, but the cervix is left behind. So, why might you need this type of procedure? How will it affect your menstrual cycle?

Dec 2, 2024 | cancernetwork.com | Rahul Gosain |Rohit Gosain |Shannon N. Westin

In a recent Treatment Algorithms with the Oncology Brothers program, Rohit Gosain, MD, Rahul Gosain, MD, and Shannon N. Westin, MD, MPH, FACOG, discussed treatment options for endometrial genomic subtypes. Rohit is the medical director of the Roswell Park Hematology Oncology Southtowns and an assistant professor of oncology at Roswell Park Care Network in Buffalo, NY. Rahul is the medical director of the Wilmot Cancer Institute in Webster, NY.

Oct 24, 2024 | cancernetwork.com | Rohit Gosain |Rahul Gosain |Shannon N. Westin

Patient Considerations for Immunotherapy TreatmentShannon N. Westin, MD, discusses how patient considerations for immunotherapy treatment involve evaluating individual health profiles, potential adverse effects, and the importance of personalized approaches to enhance treatment efficacy and patient quality of life.

Oct 24, 2024 | cancernetwork.com | Rohit Gosain |Rahul Gosain |Shannon N. Westin

Shannon N. Westin, MD, discusses chemotherapy options for endometrial cancer as well as the results of her phase 3 DUO-E trial.

Oct 24, 2024 | cancernetwork.com | Rohit Gosain |Rahul Gosain |Shannon N. Westin

Neoadjuvant Treatment Considerations for Endometrial CancerShannon N. Westin, MD, discusses how neoadjuvant treatment considerations for endometrial cancer can improve surgical outcomes and patient prognosis through the use of personalized, multidisciplinary approaches tailored to individual tumor characteristics.